>
Malin logo

MLC - Malin Share Price

€6.2 -0.0  -0.8%

Last Trade - 11/05/21

Sector
Healthcare
Size
Small Cap
Market Cap £264.3m
Enterprise Value £307.9m
Revenue £35.2m
Position in Universe 758th / 1826
Bullish
Bearish
Unlock MLC Revenue
Momentum
Relative Strength (%)
1m -2.34%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -0.79%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
22.9 42.1 41.9 38.0 34.9 41.0 41.0 +12.4%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, MalinCorporation plc revenues increased 17% to EUR41M. Netincome totaled EUR87.7M vs. loss of EUR5.4M. Revenuesreflect European Union segment increase of 65% to EUR11.9M,Spain segment increase of 10% to EUR19.4M. Net Incomereflects Fair value movement on reclassification increasefrom EUR5.5M to EUR97.8M (income), Equity Earnings -BeforeTaxes decrease of 45% to EUR13.5M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

MLC Revenue Unlock MLC Revenue

Net Income

MLC Net Income Unlock MLC Revenue

Normalised EPS

MLC Normalised EPS Unlock MLC Revenue

PE Ratio Range

MLC PE Ratio Range Unlock MLC Revenue

Dividend Yield Range

MLC Dividend Yield Range Unlock MLC Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
MLC EPS Forecasts Unlock MLC Revenue
Profile Summary

Malin Corporation plc is an Ireland-based global life sciences company. The Company's businesses include Altan, which is an injectable drug company; AN2H Discovery Limited, which focuses on designing novel small molecule therapeutics; Emba Medical Limited, which offers vascular embolization system; Emba Neuro Limited; Hatteras Venture Partners (HVP), which is a life sciences company; Immunocore, which is a biotechnology company; Jaan Health, which is a healthcare mobile technology company; Melinta Therapeutics, Inc.; Novan, Inc., which is a clinical stage company; Poseida Therapeutics, Inc., which is a human therapeutics company, and Viamet Pharmaceuticals, Inc., which is a drug discovery company. The Company operates through subsidiaries, and focuses on various therapeutic areas, including dermatology, anti-infective, pain, immunology, oncology, neurology, anatomy and other areas.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Public Since March 25, 2015
No. of Shareholders: n/a
No. of Employees: 255
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Irish Stock Exchange
Shares in Issue 49,225,187
Free Float (0.0%)
Eligible for
ISAs
SIPPs
MLC Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for MLC
Upcoming Events for MLC
Frequently Asked Questions for Malin
What is the Malin share price?

As of 11/05/21, shares in Malin are trading at €6.2, giving the company a market capitalisation of £264.3m. This share price information is delayed by 15 minutes.

How has the Malin share price performed this year?

Shares in Malin are currently trading at €6.2 and the price has moved by 0.107k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Malin price has moved by 67.67% over the past year.

What are the analyst and broker recommendations for Malin?

Of the analysts with advisory recommendations for Malin, there are there are currently 2 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Malin is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Malin next release its financial results?

Malin is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Malin dividend yield?

Malin does not currently pay a dividend.

Does Malin pay a dividend?

Malin does not currently pay a dividend.

When does Malin next pay dividends?

Malin does not currently pay a dividend.

How do I buy Malin shares?

To buy shares in Malin you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Malin?

Shares in Malin are currently trading at €6.2, giving the company a market capitalisation of £264.3m.

Where are Malin shares listed? Where are Malin shares listed?

Here are the trading details for Malin:

Country of listing: Ireland
Exchange: ISE
Ticker Symbol: MLC
What kind of share is Malin?

Based on an overall assessment of its quality, value and momentum, Malin is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Malin share price forecast 2021?

Shares in Malin are currently priced at €6.2. At that level they are trading at 17.12% discount to the analyst consensus target price of 0.00.

Analysts covering Malin currently have a consensus Earnings Per Share (EPS) forecast of -0.874 for the next financial year.

How can I tell whether the Malin share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Malin. Over the past six months, the relative strength of its shares against the market has been 35.89%. At the current price of €6.2, shares in Malin are trading at 37.79% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Malin PE Ratio?

The Malin PE ratio based on its reported earnings over the past 12 months is 3.19. The shares are currently trading at €6.2.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Malin?

Malin's management team is headed by:

Darragh Lyons - CFO
Owen Hughes - NED
Liam Daniel - NEC
Neil McLoughlin - GCN
Fiona Dunlevy - OTH
David Dobrosky - OTH
Peter Schwartzman - OTH
Jean-Michel Cossery - NED
Bahija Jallal - CEO
Luke Corning - NED
Kirsten Drejer - NED
Who are the major shareholders of Malin?

Here are the top five shareholders of Malin based on the size of their shareholding:

Pentwater Capital Management LP Hedge Fund
Percentage owned: 17.89% (8.22m shares)
Reedy Creek Investments, LLC. Corporation
Percentage owned: 11.7% (5.38m shares)
The Pension Protection Fund Pension Fund
Percentage owned: 11.01% (5.06m shares)
The National Treasury Management Agency Pension Fund
Percentage owned: 10.88% (5.00m shares)
Loscher (Peter) Individual Investor
Percentage owned: 4.73% (2.17m shares)
Similar to MLC
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.